Clevidipine

BreastfeedingPediatric
  • TRADE NAME: Cleviprex (The Medicines Company)
  • INDICATIONS: Reduction of blood pressure
  • CLASS: Calcium channel blocker
  • HALF-LIFE: 1 minute
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alpha-1 blockers, Amifostine, Antihypertensives, Black Cohosh, Blue Cohosh, Calicium channel blockers (non-dihydropyridine), Diazoxide, Ephedra, Ginger, Ginseng, Goldenseal, Hawthorn (Fruit, Leaf, Flower Extract), Hypotensives, Licorice, Magnesium salts, MAO inhibitors, Methylphenidate, Mistletoe, Neuromuscular blocking agents, Nitroprusside, Pentoxifylline, Phosphodiesterase 5 inhibitors, Quinidine, Quinine, Rituximab, Yohimbine

PREGNANCY CATEGORY: C

NOTE

Contra-indicated in patients with allergies to soy or egg products, with defective lipid metabolism, or severe aortic stenosis.

Our database has 14 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
RENAL.
OTHER.


Page last updated 05/09/2023

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top